Compare REGN & UPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REGN | UPS |
|---|---|---|
| Founded | 1988 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4B | 85.4B |
| IPO Year | 1991 | 1999 |
| Metric | REGN | UPS |
|---|---|---|
| Price | $769.28 | $109.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 20 |
| Target Price | ★ $802.36 | $108.11 |
| AVG Volume (30 Days) | 812.3K | ★ 4.8M |
| Earning Date | 01-30-2026 | 01-27-2026 |
| Dividend Yield | 0.46% | ★ 6.13% |
| EPS Growth | ★ 2.88 | N/A |
| EPS | ★ 41.59 | 6.56 |
| Revenue | $14,247,800,000.00 | ★ $88,661,000,000.00 |
| Revenue This Year | $2.08 | N/A |
| Revenue Next Year | $6.82 | N/A |
| P/E Ratio | $18.34 | ★ $16.31 |
| Revenue Growth | ★ 2.89 | N/A |
| 52 Week Low | $476.49 | $82.00 |
| 52 Week High | $821.11 | $136.99 |
| Indicator | REGN | UPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 63.94 |
| Support Level | $747.30 | $105.15 |
| Resistance Level | $765.00 | $110.04 |
| Average True Range (ATR) | 21.66 | 2.31 |
| MACD | -2.54 | -0.13 |
| Stochastic Oscillator | 47.24 | 79.10 |
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 65% of total revenue, while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.